Beaumont Laboratory - Lab Test Details
800-551-0488

Lab results are too important to go anywhere else

Beaumont Laboratory

Inhibin A

EPIC: LAB6887, SOFT: INH

Specimen Collection Criteria

Collect: One Gold-top SST tube.

Physician Office/Drawsite Specimen Preparation

Let specimen clot 30-60 minutes then centrifuge to separate serum from cells. Refrigerate (2-8°C or 36-46°F) the centrifuged collection tube within two hours of collection.

Preparation for Courier Transport

Transport: Centrifuged collection tube, refrigerated (2-8°C or 36-46°F). (Min: 2.0 mL)

Rejection Criteria

  • Frozen specimens.
  • Hemolyzed specimens.
  • Plasma specimens.
  • Severely lipemic specimens.
  • Specimens not collected and processed as indicated.

Storage

Specimen Stability for Testing:

Centrifuged SST Tubes and Microtainers® with Separator Gels
Room Temperature (20-26°C or 68-78.8°F): 2 hours
Refrigerated (2-8°C or 36-46°F): 7 days
Frozen (-20°C/-4°F or below): Unacceptable

Red-top Tubes and Microtainers® without Separator Gels
Room Temperature (20-26°C or 68-78.8°F): 2 hours
Refrigerated (2-8°C or 36-46°F): 24 hours
Frozen (-20°C/-4°F or below): Unacceptable

Serum Specimens (Pour-Overs)
Room Temperature (20-26°C or 68-78.8°F): 2 hours
Refrigerated (2-8°C or 36-46°F): 7 days
Frozen (-20°C/-4°F or below): Unacceptable

Specimen Storage in Department Prior to Disposal:

Refrigerated (2-8°C or 36-46°F): 7 days

Laboratory

Royal Oak Special Testing Laboratory.

Performed

Monday - Friday.
Results available within 24 hours.

Reference Range

Normal Cycling Females
Early Follicular Phase (-14 to -10):
1.8-17.3 pg/mL.
Mid Follicular Phase (-9 to -4):
3.5-31.7 pg/mL.
Late Follicular Phase (-3 to -1): 9.8-90.3 pg/mL.
Mid Cycle (Day 0):
16.9-91.8 pg/mL.
Early Luteal (1 to 3):
16.1-97.5 pg/mL.
Mid Luteal (4 to 11):
3.9-87.7 pg/mL.
Late Luteal (12 to 14):
2.7-47.1 pg/mL.

IVF Peak Levels:
354.2-1690.0 pg/mL.
PCOS - Ovulatory:
5.7-16.0 pg/mL.
Postmenopausal:
Less than 6.9 pg/mL.
Normal Males:
Less than 2.1 pg/mL.

Test Methodology

Chemiluminescent Immunoassay.

Interpretation

  • In females, Inhibin A is produced mainly by the dominant follicle in the ovary and by the corpus luteum. Levels vary during the menstrual cycle and are very low once menopause occurs.
  • Serum Inhibin A is reported to be increased in about 70% of patients with granulosa cell tumors (stromal sex cord tumor). It may also be increased in a smaller percentage of patients with mucinous epithelial tumors (20%) but is less helpful in non-mucinous tumors. Most studies have been performed in menopausal women, where its utility is greater than in premenopausal women - this is because levels are normally higher and more variable in the latter group.

Clinical Utility

  • Inhibin A may aid in the diagnosis of ovarian granulosa cell tumors particularly when used in combination with Inhibin B.
  • If Inhibin A was elevated at the time of granulosa cell tumor or mucinous epithelial tumor diagnosis, Inhibin A may help in patient monitoring.

CPT Code

86336.

Test Codes

EPIC: LAB6887, SOFT: INH

Last Updated

05/04/2016

Microtainer® and Vacutainer® are registered trademarks of Becton, Dickinson and Company.
UroVysion® is a registered trademark of Abbott Laboratories. ThinPrep® is a registered trademark of Hologic, Incorporated.

This directory currently reflects information only for specimens collected and/or processed at the Farmington Hills, Grosse Pointe, Royal Oak, and Troy campuses.